all

Merck signs Covid-19 research alliance with ISB

Reading now: 697
www.pharmaceutical-technology.com

Merck (MSD) has entered a research collaboration with the Institute for Systems Biology (ISB) to study molecular mechanisms of SARS-CoV-2 and Covid-19 infection.

The partners aim to identify targets for drugs and vaccines against Covid-19. Findings from the research will be accessible to the scientific and biomedical community.

As part of the project, ISB, the Swedish Medical Center, and a consortium of research organisations and biomedical companies will test blood samples and nasal swabs.

The samples and swabs will be obtained at different time points from Covid-19 patients at the Swedish Medical Center. Proteomic, metabolomics, transcriptomic and genetic approaches will be used to analyse blood samples for Covid-19’s effect on

Read more on pharmaceutical-technology.com
The website covid-19.rehab is an aggregator of news from open sources. The source is indicated at the beginning and at the end of the announcement. You can send a complaint on the news if you find it unreliable.

Related News

DMCA